Item 16. Form 10-K Summary

Not applicable.

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Eli Lilly and Company


By						/s/ David Ricks
David Ricks
Chair, President, and Chief Executive Officer

February 12, 2026

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below on February 12, 2026 by the following persons on behalf of the Registrant and in the capacities indicated.


Signature						Title

/s/ David Ricks						Chair, President, and Chief Executive Officer (principal executive officer)
DAVID RICKS

/s/ Lucas Montarce						Executive Vice President and Chief Financial Officer (principal financial officer)
LUCAS MONTARCE

/s/ Donald Zakrowski						Senior Vice President, Finance, and Chief Accounting Officer (principal accounting officer)
DONALD ZAKROWSKI

*						Director
RALPH ALVAREZ

*						Director
KATHERINE BAICKER, Ph.D.

*						Director
CAROLYN BERTOZZI, Ph.D.

*						Director
ERIK FYRWALD

*						Director
MARY LYNNE HEDLEY, Ph.D.

*						Director
JAMERE JACKSON

*						Director
KIMBERLY JOHNSON

*						Director
WILLIAM KAELIN, JR., M.D.

*						Director
JUAN LUCIANO

*						Director
JON MOELLER

*						Director
GABRIELLE SULZBERGER


*By			/s/ Lucas Montarce
			LUCAS MONTARCE As Attorney-in-Fact

Previous: Item 15. Exhibits and Financial Statement Schedules